12 Project Grants have been secured by Queen’s University, totaling over $15 million in funding from the Canadian Institutes of Health Research

Queen’s researcher Chris Booth was inducted as a Fellow in the Canadian Academy of Health Sciences.

The Conversation: Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments.

The Conversation: In future health emergencies and possibly further waves of the COVID-19 pandemic, caution needs to be taken when extending cancer waiting times for reasons unrelated to patients’ health-care needs.

$30 million in funding from the Canadian Cancer Society ensures that the research conducted by the Canadian Cancer Trials Group continues to have meaningful impact on the lives of people with cancer.

To recognize World Cancer Day, Queen’s is highlighting current partnerships and research projects to develop novel treatments, support better outcomes, and advance quality of life for people with cancer globally.

Patients in most countries do not have access to basic cancer medicines, according to new research from Christopher Booth (Oncology) and collaborators at the World Health Organization (WHO).

Queen’s researcher Elizabeth Eisenhauer has received the 2021 Canada Gairdner Wightman award for outstanding leadership in medicine and medical science.

More than $10 million has been secured by Queen’s researchers for infrastructure that will help to combat climate change, treat cancer, and understand the fabric of the universe.